229 related articles for article (PubMed ID: 36543888)
1. Construction of a machine learning-based artificial neural network for discriminating PANoptosis related subgroups to predict prognosis in low-grade gliomas.
Chen G; He Z; Jiang W; Li L; Luo B; Wang X; Zheng X
Sci Rep; 2022 Dec; 12(1):22119. PubMed ID: 36543888
[TBL] [Abstract][Full Text] [Related]
2. Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas.
Zhou Z; Wei J; Jiang W
Sci Rep; 2022 Mar; 12(1):5457. PubMed ID: 35361903
[TBL] [Abstract][Full Text] [Related]
3. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
Song J; Xu Z; Fan Q; Sun Y; Lin X
Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
[TBL] [Abstract][Full Text] [Related]
4. Characterization of aging cancer-associated fibroblasts draws implications in prognosis and immunotherapy response in low-grade gliomas.
Zhou Z; Wei J; Kuang L; Zhang K; Liu Y; He Z; Li L; Lu B
Front Genet; 2022; 13():897083. PubMed ID: 36092895
[No Abstract] [Full Text] [Related]
5. Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics.
Wang B; Feng Y; Li Z; Zhou F; Luo J; Yang B; Long S; Li X; Liu Z; Li X; Chen J; Wang L; Wei W
Life Sci; 2024 Jan; 336():122312. PubMed ID: 38042284
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns and immunological characterization of PANoptosis -related genes in gastric cancer.
Qing X; Jiang J; Yuan C; Xie K; Wang K
Front Endocrinol (Lausanne); 2023; 14():1222072. PubMed ID: 37664853
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis.
Dai W; Zheng P; Wu J; Chen S; Deng M; Tong X; Liu F; Shang X; Qian K
Front Immunol; 2023; 14():1247131. PubMed ID: 38239341
[TBL] [Abstract][Full Text] [Related]
8. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas.
Zhou Z; Wei J; Lu B; Jiang W; Bao Y; Li L; Wang W
Front Genet; 2021; 12():763807. PubMed ID: 35198000
[No Abstract] [Full Text] [Related]
10. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
Jiang H; Sun Z; Li F; Chen Q
Front Immunol; 2022; 13():983569. PubMed ID: 36405708
[TBL] [Abstract][Full Text] [Related]
11. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
12. Identification of WHO II/III Gliomas by 16 Prognostic-related Gene Signatures using Machine Learning Methods.
Wu YM; Sa Y; Guo Y; Li QF; Zhang N
Curr Med Chem; 2022; 29(9):1622-1639. PubMed ID: 34455959
[TBL] [Abstract][Full Text] [Related]
13. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
Wang X; Sun R; Chan S; Meng L; Xu Y; Zuo X; Wang Z; Hu X; Han Q; Dai L; Bai T; Yu Z; Wang M; Yang W; Zhang H; Chen W
Front Genet; 2022; 13():955355. PubMed ID: 36186438
[TBL] [Abstract][Full Text] [Related]
14. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
[TBL] [Abstract][Full Text] [Related]
15. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.
Zhang B; Huang B; Zhang X; Li S; Zhu J; Chen X; Song H; Shang D
Front Oncol; 2023; 13():1217654. PubMed ID: 37519797
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
17. Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma.
Zhang Z; Zhang F; Pang P; Li Y; Chen X; Sun S; Bian Y
Front Cell Dev Biol; 2023; 11():1210456. PubMed ID: 37325556
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
19. Characterization of PANoptosis-related genes in Crohn's disease by integrated bioinformatics, machine learning and experiments.
Yang Y; Hounye AH; Chen Y; Liu Z; Shi G; Xiao Y
Sci Rep; 2024 May; 14(1):11731. PubMed ID: 38778086
[TBL] [Abstract][Full Text] [Related]
20. Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer.
Yu T; Cheng W; Zhang J; Wang T; Liu Y; Duan Y; Hu A; Feng J; Li M; Li Y; Zhang H; Rong Z; Shang Y; Shakila SS; Ma F; Guo B
J Cancer; 2024; 15(2):428-443. PubMed ID: 38169571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
